2013
DOI: 10.1021/pr300785h
|View full text |Cite
|
Sign up to set email alerts
|

Protein Changes in Immunodepleted Cerebrospinal Fluid from a Transgenic Mouse Model of Alexander Disease Detected Using Mass Spectrometry

Abstract: Cerebrospinal fluid (CSF) is a low protein content biological fluid with dynamic range spanning at least nine orders of magnitude in protein content and is in direct contact with the brain. A modified IgY-14 immunodepletion treatment was performed to enhance analysis of the low volumes of CSF that are obtainable from mice. As a model system in which to test this approach, we utilized transgenic mice that over-express the intermediate filament glial fibrillary acidic protein (GFAP). These mice are models for Al… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
26
0

Year Published

2014
2014
2015
2015

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 21 publications
(26 citation statements)
references
References 54 publications
0
26
0
Order By: Relevance
“…Moreover, our workflow increases proteomic depth, as the number of protein identifications were two-to threefold higher compared with previous studies (6,7). This is a clear step forward toward the goal of determining the whole mouse CSF proteome.…”
Section: Discussionmentioning
confidence: 87%
See 3 more Smart Citations
“…Moreover, our workflow increases proteomic depth, as the number of protein identifications were two-to threefold higher compared with previous studies (6,7). This is a clear step forward toward the goal of determining the whole mouse CSF proteome.…”
Section: Discussionmentioning
confidence: 87%
“…Full MS spectra were recorded at a resolution of 70,000 over a mass range between m/z 400 -1800. The automatic gain control target was set to 3 ϫ 10 6 and a maximum injection time of 50 ms was allowed. The 10 most intense peptide ions were chosen for fragmentation.…”
Section: Human Csf Samples-humanmentioning
confidence: 99%
See 2 more Smart Citations
“…Mass-spectrometry has been used to detect small amounts of GFAP and better characterise the post-translational modifications of GFAP (Herskowitz et al, 2010;Cunningham et al, 2013;Hanrieder et al, 2009;Ishigami et al, 2005;Joachim et al, 2007;Nomura et al, 2009;Ekegren et al, 2006). An important finding from these studies was that compared to other proteins GFAP is an extremely stable and robust candidate biomarker for massspectrometry (Ekegren et al, 2006).…”
Section: Mass-spectrometrymentioning
confidence: 99%